Complement factor 5a (C5a) is a promising candidate for immunomodulatory therapies of sepsis [4]–[7], since it has been characterised as potent mediator of the innate immune system to infection and ‘key’ mediator of sepsis and septic organ dysfunction [1], [4]–[12]. The gene discussed is C5; the disease is Sepsis.